Fig. 3From: Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancerSurface marker profile of EVs isolated from lymphatic drainage fluid obtained from breast cancer patients. EV surface proteins were profiled using multiplex bead-based flow cytometry assay. Captured EVs were counterstained with APC-labeled detection antibodies (mixture of anti-CD9, anti-CD63, and anti-CD81 antibodies). The 24 out of 37 proteins that were found to be positive (MFI > 20) in any of the patients are shown in the figure. Data is presented as CD9/CD63/CD81 normalized background subtracted (isotype control and blank samples) median fluorescence intensity (MFI). Asterisks indicate proteins detected in all patientsBack to article page